59 related articles for article (PubMed ID: 19958550)
1. Dual-Targeting of the HER2 Cancer Receptor with an Antibody-Directed Enzyme and a Nanobody-Guided MMAE Prodrug Scaffold.
Smidt JM; Märcher A; Skaanning MK; El-Chami K; Teodori L; Omer M; Kjems J; Gothelf KV
Chembiochem; 2024 Jun; ():e202400437. PubMed ID: 38945824
[TBL] [Abstract][Full Text] [Related]
2. Complementation Dependent Enzyme Prodrug Therapy Enables Targeted Activation of Prodrug on HER2-Positive Cancer Cells.
Nervig CS; Hatch ST; Owen SC
ACS Med Chem Lett; 2022 Nov; 13(11):1769-1775. PubMed ID: 36385932
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug.
Wang Y; Yuan H; Wright SC; Wang H; Larrick JW
BMC Chem Biol; 2001; 1(1):4. PubMed ID: 11710971
[TBL] [Abstract][Full Text] [Related]
4. Heterologous Expression, Purification, and Characterization of the HspX, Ppe44, and EsxV Proteins of
Amini Y; Tafaghodi M; Amel Jamehdar S; Meshkat Z; Moradi B; Sankian M
Rep Biochem Mol Biol; 2018 Apr; 6(2):125-130. PubMed ID: 29765994
[TBL] [Abstract][Full Text] [Related]
5. Use of E. coli Purine Nucleoside Phosphorylase in the Treatment of Solid Tumors.
Parker WB; Sorscher EJ
Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29119917
[TBL] [Abstract][Full Text] [Related]
6. Antitumor effects of a dual-specific lentiviral vector carrying the Escherichia coli purine nucleoside phosphorylase gene.
Wang X; Sun L; Sun X; Yu J; Wang K; Wu Y; Gao Q; Zheng J
Int J Oncol; 2017 May; 50(5):1612-1622. PubMed ID: 28393254
[TBL] [Abstract][Full Text] [Related]
7. Translating antibody directed enzyme prodrug therapy (ADEPT) and prospects for combination.
Sharma SK; Bagshawe KD
Expert Opin Biol Ther; 2017 Jan; 17(1):1-13. PubMed ID: 27737561
[TBL] [Abstract][Full Text] [Related]
8. Antibody-enzyme conjugates for cancer therapy.
Melton RG; Sherwood RF
J Natl Cancer Inst; 1996 Feb; 88(3-4):153-65. PubMed ID: 8632489
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT.
Afshar S; Olafsen T; Wu AM; Morrison SL
J Exp Clin Cancer Res; 2009 Dec; 28(1):147. PubMed ID: 19958550
[TBL] [Abstract][Full Text] [Related]
10. Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer.
Afshar S; Asai T; Morrison SL
Mol Cancer Ther; 2009 Jan; 8(1):185-93. PubMed ID: 19139128
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of an anti-CD16 single-chain Fv fragment and construction of an anti-HER2/neu/anti-CD16 bispecific scFv that triggers CD16-dependent tumor cytolysis.
McCall AM; Adams GP; Amoroso AR; Nielsen UB; Zhang L; Horak E; Simmons H; Schier R; Marks JD; Weiner LM
Mol Immunol; 1999 May; 36(7):433-45. PubMed ID: 10449096
[TBL] [Abstract][Full Text] [Related]
12. Chimeric TNT-3/human beta-glucuronidase fusion proteins for antibody-directed enzyme prodrug therapy (ADEPT).
Biela BH; Khawli LA; Hu P; Epstein AL
Cancer Biother Radiopharm; 2003 Jun; 18(3):339-53. PubMed ID: 12954121
[TBL] [Abstract][Full Text] [Related]
13. Toward antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1 and novel in vivo stable prodrugs of methotrexate.
Smith GK; Banks S; Blumenkopf TA; Cory M; Humphreys J; Laethem RM; Miller J; Moxham CP; Mullin R; Ray PH; Walton LM; Wolfe LA
J Biol Chem; 1997 Jun; 272(25):15804-16. PubMed ID: 9188478
[TBL] [Abstract][Full Text] [Related]
14. Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2'-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine.
Afshar S; Sawaya MR; Morrison SL
Protein Sci; 2009 May; 18(5):1107-14. PubMed ID: 19388075
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
